Faculty of 1000 evaluation for The role of ligand efficiency metrics in drug discovery.

Author(s):  
Mark Murcko
2014 ◽  
Vol 13 (2) ◽  
pp. 105-121 ◽  
Author(s):  
Andrew L. Hopkins ◽  
György M. Keserü ◽  
Paul D. Leeson ◽  
David C. Rees ◽  
Charles H. Reynolds

2019 ◽  
Vol 44 (10) ◽  
pp. 897-898 ◽  
Author(s):  
Rachel M. Johnson ◽  
Anna J. Higgins ◽  
Stephen P. Muench

2020 ◽  
Vol 107 (4) ◽  
pp. 796-805 ◽  
Author(s):  
Daniela J. Conrado ◽  
Sridhar Duvvuri ◽  
Hugo Geerts ◽  
Jackson Burton ◽  
Carla Biesdorf ◽  
...  

2021 ◽  
Author(s):  
Brian T. Pentland ◽  
Youngjin Yoo ◽  
Jan Recker ◽  
Inkyu Kim

We offer a path-centric theory of emerging technology and organizing that addresses a basic question. When does emerging technology lead to transformative change? A path-centric perspective on technology focuses on the patterns of actions afforded by technology in use. We identify performing and patterning as self-reinforcing mechanisms that shape patterns of action in the domain of emerging technology and organizing. We use a dynamic simulation to show that performing and patterning can lead to a wide range of trajectories, from lock-in to transformation, depending on how emerging technology in use influences the pattern of action. When emerging technologies afford new actions that can be flexibly recombined to generate new paths, decisive transformative effects are more likely. By themselves, new affordances are not likely to generate transformation. We illustrate this theory with examples from the practice of pharmaceutical drug discovery. The path-centric perspective offers a new way to think about generativity and the role of affordances in organizing.


Sign in / Sign up

Export Citation Format

Share Document